Californian biopharmaceutical firm Amgen as reported a 2% drop in revenues in the first quarter, to $6.1 billion, a reflection of falling sales of COVID-19 ther 28 April 2023
As part of its reorganization around key therapy areas of oncology and immunology, Belgian biotech company Galapagos is hiving off certain research functions. 31 March 2023
A new oncology-focused spinout will be launched by Citius Pharmaceuticals, with the goal of developing the immuno-oncology asset I/ONTAK. 31 March 2023
Cancer immunotherapies and predictive biomarkers company Jounce Therapeutics has agreed to be acquired by Concentra Biosciences for $1.85 in cash per share plus 27 March 2023
Germany’s Merck KGaA has regained exclusive worldwide rights to develop, manufacture, and commercialize its checkpoint blocker Bavencio (avelumab). 27 March 2023
An analysis of the recent investment activity in antibody–drug conjugates (ADCs) prior to Pfizer's newly-announced $43 billion takeover of Seagen. 13 March 2023